Health Discovery Corporation's Executives to Present at "Personalized Medicine Partnerships" Conference This Morning
Last update: 2/24/2010 9:00:04 AM
SAVANNAH, Ga., Feb 24, 2010 (BUSINESS WIRE) -- Health Discovery Corporation (HDVY) ("HDC"), announced that two members of its senior management team will be speaking at the "Personalized Medicine Partnerships" conference taking place today in Philadelphia, PA. The conference is sponsored by Arrowhead Conferences, a business-to-business conference group based in Redlands, Calif.
Stephen D. Barnhill, M.D., Chairman and CEO, and John A. Norris, J.D., M.B.A., COO, of Health Discovery Corporation, will make a presentation describing the value of partnerships in furtherance of personalized medicine.
The Company has developed strong relationships with leading companies such as Quest Diagnostics Incorporated, and Abbott Laboratories to commercialize HDC's non-invasive, four-gene test for clinically-significant prostate cancer, among other initiatives.
Other presenters include representatives from Pfizer, AstraZeneca, Merck, J&J, Medco, Roche, PriceWaterhouseCoopers, LabCorp, Abbott, FDA, NCI, The European Commission, and The National Human Genome Institute.
About Health Discovery Corporation
Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology.
